# Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)

> **NCT06615128** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 66 (estimated)

## Conditions studied

- Assessment of Serum Level of SCD25 in RA, SSc (with or Without ILD) and IPF and Its Correlation with Disease Activity

## Interventions

- **DIAGNOSTIC_TEST:** blood sampling

## Key facts

- **NCT ID:** NCT06615128
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06615128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06615128, "Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06615128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*